U.S., Dec. 17 -- ClinicalTrials.gov registry received information related to the study (NCT07286331) titled 'A Study to Investigate GSK5733584 Compared With Chemotherapy in Participants With Recurrent Endometrial Cancer (BEHOLD-Endometrial01)' on Dec. 12.
Brief Summary: This study specifically aims to evaluate how well GSK5733584 works in treating Endometrial Cancer (EC) compared to standard of care. The study also assesses whether GSK5733584 is safe and tolerated well by participants in comparison to standard of care and will help provide a better understanding of the main side effects of the drugs
Study Start Date: March 05, 2026
Study Type: INTERVENTIONAL
Condition:
Neoplasms, Endometrial
Intervention:
DRUG: GSK5733584
GSK5733584...